Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of leiomyoma arising from the uterine corpus. It is characterized by a dense cellular infiltrate composed of spindle or round cells with scant cytoplasm and a less obvious interlacing fascicle pattern.
Biomarker and diagnostic research for uterine corpus cellular leiomyoma has been reported in the published literature.
No clinical trials have been registered for uterine corpus cellular leiomyoma.
107 publications have been identified in PubMed for uterine corpus cellular leiomyoma. Research spans Basic Science / Preclinical (34%), Review / Meta-Analysis (25%), and Case Report / Case Series (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 35 | 34% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
Research summaries
26 |
25% |
Patient case studies | 20 | 20% |
Disease patterns and progression | 8 | 8% |
New treatment approaches | 7 | 7% |
Testing and diagnosis research | 5 | 5% |
Clinical study results | 1 | 1% |
Wei LL (2026). [PMID: 42245742](https://pubmed.ncbi.nlm.nih.gov/42245742/). *Front Oncol*. [Case Report / Case Series]
Lai H (2026). [PMID: 41309409](https://pubmed.ncbi.nlm.nih.gov/41309409/). *Int J Gynecol Cancer*. [Epidemiology / Natural History]
Luo W (2026). [PMID: 42196565](https://pubmed.ncbi.nlm.nih.gov/42196565/). *Int J Mol Sci*. [Basic Science / Preclinical]
Aitmagambetova M (2026). [PMID: 41741121](https://pubmed.ncbi.nlm.nih.gov/41741121/). *BMJ Case Rep*. [Case Report / Case Series]
Tanioka S (2026). [PMID: 41493967](https://pubmed.ncbi.nlm.nih.gov/41493967/). *PLoS One*. [Basic Science / Preclinical]
Şimşek E (2026). [PMID: 41605457](https://pubmed.ncbi.nlm.nih.gov/41605457/). *J Obstet Gynaecol Res*. [Epidemiology / Natural History]
Haiyun Y (2026). [PMID: 42125784](https://pubmed.ncbi.nlm.nih.gov/42125784/). *Histol Histopathol*. [Diagnostic / Biomarker]
Yu Y (2025). [PMID: 40219728](https://pubmed.ncbi.nlm.nih.gov/40219728/). *Pharm Biol*. [Basic Science / Preclinical]
Merino-Pérez A (2025). [PMID: 40450431](https://pubmed.ncbi.nlm.nih.gov/40450431/). *Reprod Biomed Online*. [Review / Meta-Analysis]
Boldu-Fernández S (2025). [PMID: 39936948](https://pubmed.ncbi.nlm.nih.gov/39936948/). *Cells*. [Review / Meta-Analysis]